CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing innovative therapeutics and pharmaceutical products. The firm is also involved in developing innovative therapeutics addressing cancer and other unmet medical needs for the global market. The company was founded in 1991 and is headquartered in Beijing, China.
Current Value
$5.161 Year Return
Current Value
$5.161 Year Return
Market Cap
$70.36M
P/E Ratio
-2.36
1Y Stock Return
-6.25%
1Y Revenue Growth
-42.92%
Dividend Yield
0.00%
Price to Book
4.4
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Yahoo
CASI Pharmaceuticals ( NASDAQ:CASI ) Third Quarter 2024 Results Key Financial Results Revenue: US$7.79m (down 12% from...
Yahoo
BEIJING, CHINA / ACCESSWIRE / November 15, 2024 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI) ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company specializing in the development and commercialization of innovative therapeutics ...
Finnhub
CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2024 BUSINESS AND FINANCIAL RESULTS BEIJING, China CASI Pharmaceuticals, Inc. , a Cayman incorporated biopharmaceutical...
Yahoo
BEIJING, CHINA / ACCESSWIRE / October 24, 2024 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a biopharmaceutical company specializing in the development and commercialization of innovative therapeutic and pharmaceutical products announced that the Center ...
Yahoo
CASI Pharmaceuticals, Inc. ( NASDAQ:CASI ) shareholders might be concerned after seeing the share price drop 22% in the...
Yahoo
CASI Pharmaceuticals, Inc. (Nasdaq: CASI) ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company specializing in the development and commercialization of innovative therapeutics and pharmaceutical products, today announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference taking place September 9-11, 2024, at the Lotte New York Palace in New York City. Members of the CASI management team, including Chief Financial Officer Daniel Lang, MD, and C
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FIZZ | 26.04% | $4.45B | +4.19% | 0.00% |
CARE | 22.37% | $434.68M | +48.11% | 0.00% |
GAN | 21.84% | $82.94M | +20.53% | 0.00% |
T | 21.80% | $164.89B | +42.12% | 4.83% |
BA | 21.49% | $107.21B | -34.79% | 0.00% |
HROW | 21.49% | $1.56B | +377.48% | 0.00% |
ATEX | 21.37% | $618.69M | +6.68% | 0.00% |
PENN | 21.18% | $3.09B | -21.75% | 0.00% |
ZNTL | 21.10% | $226.62M | -69.48% | 0.00% |
GILT | 20.60% | $296.77M | -16.85% | 0.00% |
AIZ | 20.01% | $11.55B | +37.38% | 1.28% |
AVNS | 19.78% | $828.15M | -15.56% | 0.00% |
VRDN | 19.36% | $1.55B | +25.13% | 0.00% |
MGM | 19.23% | $11.32B | -5.80% | 0.00% |
PSTX | 19.19% | $264.13M | +3.83% | 0.00% |
OFG | 19.19% | $2.04B | +31.90% | 2.17% |
INFN | 18.92% | $1.57B | +57.01% | 0.00% |
NFBK | 18.70% | $570.62M | +35.03% | 3.91% |
PRPL | 18.70% | $91.23M | +22.95% | 0.00% |
SPR | 18.37% | $3.67B | +21.86% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CMG | -22.29% | $81.73B | +35.16% | 0.00% |
ROL | -12.47% | $24.04B | +24.01% | 1.23% |
HRTG | -12.32% | $377.42M | +62.70% | 0.00% |
PAYC | -12.28% | $12.69B | +27.90% | 0.66% |
BVN | -11.53% | $3.12B | +34.06% | 0.00% |
BROS | -10.83% | $5.93B | +80.24% | 0.00% |
GRAL | -10.58% | $508.58M | -3.65% | 0.00% |
CART | -10.50% | $11.12B | +72.59% | 0.00% |
TPL | -10.44% | $34.82B | +180.72% | 0.57% |
XOS | -10.41% | $32.60M | -58.61% | 0.00% |
LPTH | -9.93% | $59.50M | +22.95% | 0.00% |
ADUS | -9.77% | $2.19B | +36.14% | 0.00% |
LQDA | -9.76% | $859.06M | +51.04% | 0.00% |
HCI | -9.73% | $1.16B | +28.66% | 1.44% |
DPZ | -9.72% | $15.40B | +20.67% | 1.28% |
VIRT | -9.66% | $3.25B | +113.85% | 2.55% |
TNET | -9.58% | $4.58B | -18.27% | 0.81% |
NMM | -9.53% | $1.55B | +121.75% | 0.39% |
MRK | -9.42% | $252.61B | -1.79% | 3.06% |
LLY | -9.04% | $711.91B | +26.02% | 0.68% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CVNA | -0.01% | $31.92B | +692.28% | 0.00% |
SNA | -0.01% | $18.98B | +31.58% | 2.13% |
CME | -0.01% | $81.64B | +7.34% | 2.00% |
ABNB | -0.03% | $83.26B | +3.27% | 0.00% |
ALTG | -0.03% | $249.75M | -26.01% | 3.00% |
AWI | 0.03% | $6.85B | +88.40% | 0.72% |
MTA | 0.04% | $284.42M | +10.32% | 0.00% |
INVX | 0.04% | $1.17B | -22.84% | 0.00% |
TX | -0.05% | $6.55B | -13.77% | 9.29% |
CRVO | 0.05% | $79.07M | -3.91% | 0.00% |
KBR | -0.05% | $8.03B | +15.10% | 0.96% |
COIN | -0.06% | $73.91B | +170.23% | 0.00% |
TRS | 0.07% | $1.08B | +9.60% | 0.61% |
HVT | 0.07% | $379.52M | -25.02% | 5.34% |
HD | -0.07% | $407.70B | +32.75% | 2.15% |
MELI | -0.07% | $99.78B | +29.06% | 0.00% |
NSIT | -0.07% | $4.76B | +0.05% | 0.00% |
TMDX | 0.07% | $2.66B | +15.07% | 0.00% |
MOGO | -0.07% | $37.20M | +25.62% | 0.00% |
CMRE | -0.08% | $1.68B | +49.10% | 3.24% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
MNA | 19.52% | $220.86M | 0.77% |
CEFS | 18.63% | $237.38M | 5.81% |
BBH | 18.61% | $404.59M | 0.35% |
JETS | 18.00% | $1.05B | 0.6% |
AMDY | 17.48% | $145.06M | 0.99% |
JUCY | 17.43% | $325.31M | 0.6% |
IBB | 17.14% | $6.64B | 0.45% |
SRVR | 17.09% | $443.64M | 0.55% |
PCEF | 16.84% | $808.32M | 3.08% |
RSPH | 16.64% | $879.32M | 0.4% |
FDL | 16.62% | $4.55B | 0.45% |
IYZ | 16.59% | $492.05M | 0.4% |
PBW | 16.44% | $297.98M | 0.65% |
ESPO | 16.39% | $275.42M | 0.56% |
MOAT | 16.04% | $15.77B | 0.46% |
RSPF | 15.95% | $314.60M | 0.4% |
IAK | 15.81% | $755.17M | 0.39% |
VOE | 15.78% | $18.28B | 0.07% |
GNOM | 15.71% | $71.22M | 0.5% |
FPEI | 15.46% | $1.49B | 0.85% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
EQLS | -13.74% | $8.88M | 1% |
BTAL | -10.44% | $379.51M | 1.43% |
DBB | -9.74% | $129.56M | 0.77% |
DBA | -9.31% | $768.98M | 0.93% |
CTA | -8.24% | $359.48M | 0.78% |
PFFV | -6.84% | $257.51M | 0.25% |
IBHE | -6.10% | $623.02M | 0.35% |
BITO | -5.86% | $2.75B | 0.95% |
SOYB | -5.66% | $27.32M | 0.22% |
TBIL | -5.63% | $4.39B | 0.15% |
CPER | -5.61% | $160.49M | 0.97% |
KMLM | -5.55% | $348.59M | 0.9% |
FLMI | -5.52% | $360.62M | 0.3% |
AGZD | -5.50% | $142.85M | 0.23% |
USDU | -5.47% | $201.83M | 0.5% |
IBTE | -5.36% | $1.67B | 0.07% |
ICLO | -5.22% | $231.44M | 0.2% |
DEFI | -5.20% | $13.98M | 0.94% |
VIXY | -5.11% | $195.31M | 0.85% |
SHYD | -5.05% | $311.61M | 0.35% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VCAR | -<0.01% | $10.47M | 1.2% |
UDN | 0.08% | $56.31M | 0.78% |
LTPZ | 0.11% | $716.31M | 0.2% |
TBLL | -0.14% | $1.92B | 0.08% |
PSK | 0.18% | $910.73M | 0.45% |
EPU | -0.19% | $78.43M | 0.59% |
MUST | 0.20% | $410.60M | 0.23% |
GOVZ | -0.23% | $317.56M | 0.1% |
EZA | -0.23% | $299.14M | 0.59% |
DBE | 0.26% | $50.92M | 0.77% |
FTGC | -0.27% | $2.21B | 1.02% |
CONY | 0.28% | $1.04B | 1.01% |
XLY | 0.35% | $22.34B | 0.09% |
ZROZ | -0.39% | $1.64B | 0.15% |
BLOK | 0.44% | $900.68M | 0.76% |
EWH | -0.45% | $645.12M | 0.5% |
IHE | 0.48% | $596.24M | 0.39% |
FMHI | -0.49% | $753.14M | 0.7% |
ARKW | 0.53% | $1.71B | 0.87% |
REMX | 0.55% | $258.54M | 0.56% |